Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

CDNA – CareDx, Inc

CareDx, Inc.
CDNA
$19.23
Name : CareDx, Inc.
Sector : Healthcare
Industry: Diagnostics & Research
Mark. Cap: $1,070,457,664.00
EPSttm : 1.12
finviz dynamic chart for CDNA
CareDx, Inc.
$19.23
0.03%
$0.005

Float Short %

12.09

Margin Of Safety %

-25

Put/Call OI Ratio

0.43

EPS Next Q Diff

0.08

EPS Last/This Y

-0.4

EPS This/Next Y

0.44

Price

19.21

Target Price

29

Analyst Recom

2

Performance Q

4.8

Relative Volume

1.92

Beta

2.19

Ticker: CDNA




19 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-06-02CDNA170.620.301900
2025-06-03CDNA17.440.610.211919
2025-06-04CDNA19.290.600.111930
2025-06-05CDNA18.760.570.481994
2025-06-06CDNA19.510.570.002020
2025-06-09CDNA19.720.570.222028
2025-06-10CDNA19.930.570.112069
2025-06-11CDNA20.090.560.782075
2025-06-12CDNA18.820.560.362107
2025-06-13CDNA18.580.57150.002105
2025-06-16CDNA19.040.580.002112
2025-06-17CDNA19.490.58100.002113
2025-06-18CDNA19.030.600.002145
2025-06-20CDNA19.120.600.602145
2025-06-23CDNA18.950.480.001756
2025-06-24CDNA18.870.475.501777
2025-06-25CDNA19.10.480.001788
2025-06-26CDNA19.260.480.041796
2025-06-27CDNA19.210.430.011922
DateSymbolLastP/C OIP/C VolTotal OI
19 items Current Page1 of 1




19 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-06-02CDNA17.09-51.3- 0.60
2025-06-03CDNA17.44-51.3- 0.60
2025-06-04CDNA19.31-51.3- 0.60
2025-06-05CDNA18.76-51.3- 0.60
2025-06-06CDNA19.50-51.3- 0.60
2025-06-09CDNA19.72-51.3- 0.60
2025-06-10CDNA19.86-51.3- 0.60
2025-06-11CDNA20.07-51.3- 0.60
2025-06-12CDNA18.83-51.3- 0.60
2025-06-13CDNA18.58-51.3- 0.60
2025-06-16CDNA19.07-51.3- 0.60
2025-06-17CDNA19.53-51.3- 0.60
2025-06-18CDNA19.03-51.3- 0.60
2025-06-20CDNA19.04-51.3- 0.60
2025-06-23CDNA18.96-51.3- 0.60
2025-06-24CDNA18.88-51.3- 0.60
2025-06-25CDNA19.10-51.3- 0.60
2025-06-26CDNA19.27-51.3- 0.60
2025-06-27CDNA19.21-51.3- 0.60
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
19 items Current Page1 of 1




19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-06-02CDNA-3.415.9912.61
2025-06-03CDNA-3.415.9912.61
2025-06-04CDNA-3.125.9912.61
2025-06-05CDNA-3.125.9912.61
2025-06-06CDNA-3.125.9912.61
2025-06-09CDNA-3.076.0512.61
2025-06-10CDNA-3.076.0512.61
2025-06-11CDNA-3.076.0512.50
2025-06-12CDNA-3.076.0512.50
2025-06-13CDNA-3.076.0512.50
2025-06-16CDNA-3.566.0512.50
2025-06-17CDNA-3.566.0512.50
2025-06-18CDNA-3.566.0512.50
2025-06-20CDNA-3.816.0512.50
2025-06-23CDNA-4.086.0312.52
2025-06-24CDNA-3.986.0312.52
2025-06-25CDNA-3.986.0312.52
2025-06-26CDNA-3.986.0312.09
2025-06-27CDNA-4.006.0312.09
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

Last Quarter Act. EPS

0.09

Avg. EPS Est. Current Quarter

0.12

Avg. EPS Est. Next Quarter

0.17

Insider Transactions

-4

Institutional Transactions

6.03

Beta

2.19

Average Sales Estimate Current Quarter

90

Average Sales Estimate Next Quarter

94

Fair Value

14.33

Quality Score

82

Growth Score

54

Sentiment Score

16

Actual DrawDown %

80.8

Max Drawdown 5-Year %

-94.9

Target Price

29

P/E

16.69

Forward P/E

116.55

PEG

P/S

3.09

P/B

2.81

P/Free Cash Flow

53.14

EPS

1.15

Average EPS Est. Cur. Y​

0.6

EPS Next Y. (Est.)

1.04

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

19.79

Relative Volume

1.92

Return on Equity vs Sector %

-7.5

Return on Equity vs Industry %

5.8

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

CareDx, Inc.
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 644
CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Allocell, a surveillance solution that monitors the level of engraftment and persistence of allogeneic cells for patients who have received cell therapy transplants; and XynQAPI, a transplant quality tracking software, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.
stock quote shares CDNA – CareDx, Inc Stock Price stock today
news today CDNA – CareDx, Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch CDNA – CareDx, Inc yahoo finance google finance
stock history CDNA – CareDx, Inc invest stock market
stock prices CDNA premarket after hours
ticker CDNA fair value insiders trading